This website uses cookies to ensure you get the best experience on our website.
Accept Cookies
Learn More
Green Journals
Home
Hijacked
Contact Us
More
Simulation
Green Recruitments
About Us
Blog
Login
Register
English
English
Français
العربية
Journal Report
CANCER JOURNAL
Download PDF
Print
Journal Information
Journal Title
CANCER JOURNAL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
ISSN
1528-9117
E-ISSN
1540-336X
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year
A+
A
B
C
2026
✓
✓
2025
✓
✓
2024
✓
✓
2023
✓
✓
2021/2022
✓
✓
2020
✓
✓
2019
✓
✓
2018
✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Monoclonal Antibodies and Antibody-Drug Conjugates
Ioannis Ntanasis-Stathopoulos, Evangelos Terpos, Meletios-Athanasios Dimopoulos
2026-9
Vol. 32
Issue 5
DOI:
10.1097/ppo.0000000000000845
CAR-T Cell Therapy: Engineering Remission in Refractory Myeloma
Adam S. Sperling
2026-9
Vol. 32
Issue 5
DOI:
10.1097/ppo.0000000000000854
Tailoring Therapy for Frail and Elderly Myeloma Patients
Thomas George, Raphael E. Szalat
2026-9
Vol. 32
Issue 5
DOI:
10.1097/ppo.0000000000000850
Beyond Immunomodulatory Drugs: Next-Generation Cereblon Modulators in Multiple Myeloma
Lorenzo Cani, Roberto Mina, Sagar Lonial
2026-9
Vol. 32
Issue 5
DOI:
10.1097/ppo.0000000000000851
Risk Stratification in Myeloma
Anaïs Schavgoulidze, Jill Corre
2026-9
Vol. 32
Issue 5
DOI:
10.1097/ppo.0000000000000844
Smoldering and Early Disease Interception
Borja Puertas, Elena Alejo, María-Victoria Mateos
2026-9
Vol. 32
Issue 5
DOI:
10.1097/ppo.0000000000000848
Minimal Residual Disease (MRD) in Multiple Myeloma: From Prognostic Marker to Therapeutic Compass
Luis-Esteban Tamariz-Amador, Paula Rodriguez-Otero, Andrea Manubens et al.
2026-9
Vol. 32
Issue 5
DOI:
10.1097/ppo.0000000000000846
Proteostasis as a Therapeutic Backbone: Proteasome Inhibitors and Emerging Regimens
Yan Song, Poy Theprungsirikul, Annamaria Gulla et al.
2026-9
Vol. 32
Issue 5
DOI:
10.1097/ppo.0000000000000852
T-Cell Redirecting Antibodies for the Treatment of Multiple Myeloma: Off-the-Shelf T-Cell Immunity
Niels W.C.J. van de Donk, Febe Smits, Chloe O’Neill et al.
2026-9
Vol. 32
Issue 5
DOI:
10.1097/ppo.0000000000000847
Toward a Cure in Multiple Myeloma: Redefining Induction Therapy and the Role of Autologous Stem Cell Transplant
Advait Joshi, Benjamin R. Puliafito, Diana D. Cirstea et al.
2026-9
Vol. 32
Issue 5
DOI:
10.1097/ppo.0000000000000853
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 11, 2026 06:43